Loading clinical trials...
Loading clinical trials...
A Phase 3, Double-blind, Randomized, Placebo-controlled Study to Assess the Safety and Efficacy of a Single Oral Administration of Nolasiban to Increase On-going Pregnancy Rate Following Fresh Single Blastocyst Transfer Resulting From IVF
Conditions
Interventions
Nolasiban
Placebo
Locations
50
Belgium
Site 1001
Brussels, Belgium
Site 1002
Brussels, Belgium
Site 1003
Brussels, Belgium
Site 1004
Brussels, Belgium
Site 1404
Burnaby, Canada
Site 1401
Montreal, Canada
Start Date
January 10, 2019
Primary Completion Date
November 21, 2019
Completion Date
November 11, 2020
Last Updated
September 9, 2021
NCT06826365
NCT07153367
NCT07462065
NCT04872660
NCT05903859
NCT06742437
Lead Sponsor
ObsEva SA
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions